InvestorsHub Logo

OneDay4488

11/10/21 7:08 PM

#34179 RE: DonDonDonDon #34178

The issue is if we are ALL in with Covid only and do not get the approvals we are below $3.. we all know that LENZ is real and is needed but the politics overpowers what maybe best. It’s all about vaccines as the big pharms have the bigger pockets for the lobbyist. Currently there is zero interest in Therapeutics. Sad but true

10nisman

11/11/21 12:07 AM

#34184 RE: DonDonDonDon #34178

We could get approval in the UK any day and might get approval in the US within a few months. An approval in Europe might also come quickly. Humanigen doesn't really have to do anything more except fill out some applications and wait. The ACTIV-5 trial is paid for. Have you seen the multi-billion dollar contracts that the newly approved Covid drugs are receiving?

Oh Donny Boy... Trying to pump-up your losing HGEN position?

HGEN has no production. None. Zippo. Zero. Nothing. Yet, because others are getting multi-billion dollar contracts you think the UK, Europe or the U.S. is going to approve Lenz that has no production and at best can produce 100k treatments in the next 12 months, which costs a ridiculous amount to produce per treatment and shows marginable benefits at best?

Let's get back in reality boys and girls...

Vaccine rates have moved up significantly and continue to move substantially higher as children become vaccinated, booster shots for adults are and continue to become more readily available (and are dirty cheap) and thus, herd immunity will be here in no time. Throw in PFE's Paxlovid Antiviral drug and the need for Lenz falls by the second.

Lenz might be used to treat Covid for decades.

Yeah, not going to happen, but good idea in trying to create some long-term value in your financial model.